Growing the love for investing
Results 1 - 10 of 398 : 1 2 3 4 5 6 7 8 9 Next
Get RSS Feed for Biotechnology
3 Companies That Put the "Tech" in "Biotech"
From 3-D modeling to tamper-resistant drugs to personalized genomics, these companies put the "tech" in "biotech."
Three European panel recommendations, a clinical update for a lead drug candidate, and a biotech splitting into two companies, are the lead stories this week.
5 Must-Watch Earnings Reports in the Health-Care Sector This Week
With nearly six dozen health-care companies reporting earnings this week, consider these five the most important.
Four positive clinical trials had investors jumping for joy in the biotech sector this week.
More Than an Obesity Drug Company
Arena Pharmaceuticals presses on as it waits to launch its obesity drug Belviq.
A "breakthrough therapy" designation, an accelerated new drug application go-ahead from the Food and Drug Administration, and plenty of analyst upgrades dominated the biotech scene this week.
Wall Street Backs the Wrong Biotech
Are these Wall Street upgrades really deserved?
3 Humongous Health-Care Stocks This Week
Two drugmakers, and one drug retailer. These three health-care stocks experienced a humongous week.
The 1 Biotech Stock Warren Buffett Should Buy
Buffett generally shuns biotech, but one company in particular meets all the criteria he typically looks for, including sustainability, growth, and income.
Health Care's Sweet 16 Stocks: Gilead vs. Amgen
The Motley Fool's exclusive bracket decides what health-care stock is the best investment
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK